Combination cancer vaccine effective in mouse models

Combination cancer vaccine effective in mouse models

Written by Timothy Huzar on November 17, 2020 — Fact checked by Harriet Pike, Ph.D.

Scientists have developed a new vaccine for treating cancer. It combines chemotherapy and immunotherapy, and it has shown promise in mouse models.


Share on PinterestImage credit: gevende / Getty Images

A team of scientists has recently developed a new vaccine for treating cancer, and it has shown promising results in mice — even in difficult-to-treat cancer.

The treatment combines chemotherapy and immunotherapy in a single injection, which may open the door to a personalized, highly effective, and easy-to-administer therapy.

The research, which appears in the journal Nature Communications, will now need to move to preclinical trials, which may then lead to trials in humans.

Cancer treatment

Two key approaches to treating cancer are chemotherapy and immunotherapy.

According to the National Cancer Institute (NCI), chemotherapy aims to kill cancer cells by stopping or reducing their growth.

However, it can also affect healthy cells, so it typically causes significant side effects for the person receiving it. These effects may include tiredness, nausea, hair loss, and mouth sores.

On the other hand, the NCI explain that immunotherapy mobilizes a person’s immune system to target cancer cells.

Often, the immune system will do this without any support. However, cancers can protect themselves from a person’s immune system. Immunotherapy helps increase the immune system’s effectiveness.

Immunotherapy also comes with side effects, which will vary depending on the type of immunotherapy a person is receiving. Furthermore, for the most difficult-to-treat cancers — such as triple-negative breast cancer — immunotherapy generally has limited effects.

According to co-first study author Dr. Hua Wang, an assistant professor in the Department of Materials Science and Engineering at the University of Illinois at Urbana-Champaign, “Triple-negative breast cancer does not stimulate strong responses from the immune system, and existing immunotherapies have failed to treat it.”

“In our system, the immunotherapy attracts numerous immune cells to the tumor while the chemotherapy produces a large number of dead cancer cell fragments that the immune cells can pick up and use to generate an effective tumor-specific response.”

By combining the two cancer treatments, the scientists behind the new research are hoping to get the “best of both worlds.”

Source

Leave a Reply

Your email address will not be published. Required fields are marked *